Recombinant fibrils of all six Tau isoforms, as well as Sarkosyl-resistant Tau aggregates extracted from a cell culture model or AD brain tissue, could be processed by this chaperone system, demonstrating that this chaperone machinery can disintegrate disease-relevant amyloids. Here, MAPT is linked to Alzheimer disease.